The healthcare resource utilization and costs of chronic lung allograft dysfunction following lung transplantation in patients with commercial insurance in the United States.
Ajay SheshadriNaomi C SacksBridget HealeyPhil CyrGerhard BoernerHoward J HuangPublished in: Journal of medical economics (2022)
CLAD after lung transplant is associated with substantial HRU and costs. Further work is needed to develop interventions that reduce this impact.